Authors' objectives: Heart failure is a common and disabling condition that affects the heart's ability to pump blood around the body. The heart muscle doesn't receive enough oxygen to work properly and a blood vessel may completely block off, leading to a heart attack (myocardial infarction), where a section of heart muscle dies completely forming a scar. A sudden worsening of heart failure symptoms can cause fluid to enter the lungs and surrounding tissue. Furosemide sc2Wear micro-pump patch is intended to treat patients with heart failure who have increased fluid in their lungs and other tissues. This treatment aims to reduce hospital stay for patients who suffer a worsening of their heart failure. The sc2Wear micro-pump delivers the drug just under the skin by a wearable patch, rather than requiring hospital treatment where drugs are given directly into the blood by a drip. If furosemide sc2Wear micro-pump is licensed for use in the UK, it could be a new treatment option for patients with heart failure and could reduce their hospital stay. Furosemide sc2Wear micro-pump has the potential to reduce symptoms of heart failure and increase survival in this group of patients.

Project Status: Completed

Year Published: 2016

URL for published report: http://www.hsric.nihr.ac.uk/topics/furosemide-sc2wear-micro-pump-patch-for-oedema-in-heart-failure/

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

Organisation Name: NIHR Horizon Scanning Centre

Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269

Contact Name: c.packer@bham.ac.uk

Contact Email: c.packer@bham.ac.uk

Copyright: NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)